The Valley Desk

NCT00832728 · Interventional trial

Safety and Efficacy of the Extracorporeal Liver Assist Device (ELAD®) In Patients With Fulminant Hepatic Failure (FHF)

Overall registry status Withdrawn

Phase 2

Conditions Fulminant Hepatic Failure

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov